Full-Time
Pharmacy Technician
BrightSpring Health Services
10,001+ employees
Home-based and community health services, pharmacy
No salary listed
Jackson, MS, USA
In Person
 Medical, Clinical & Veterinary (1) |
|---|
Get referred to BrightSpring Health Services
See people who can refer or advise you
- A high school diploma or equivalent is required.
- A Pharmacy Technician license is required as required by the state.
- Experience in a pharmacy setting and knowledge of medical terminology are required.
- The ability to operate a computer and recognize and identify medications is required.
- The role requires attention to detail, goal orientation, teamwork, and effective oral communication.
- Fill prescription items and package medications for dispensing and delivery.
- Accurately label products, including cautionary and auxiliary labels.
- Prepare medications, including non-sterile compounding of liquids, powders, ointments, and similar products.
- Enter patient and prescription data into the computer system to generate labels.
- Participate in pharmacy inventory management, including checking stock and removing expired medications.
- Handle returned medications according to protocol, including credit or destruction.
- Communicate professionally with internal and external customers.
- Assist with onboarding and training new pharmacy staff.
- Work in the Controlled Drugs (Narcotics) Room.
- Operate automated machines to prepack medications.
- Mix IV medications and sanitize the IV room and equipment.
- Service facility-based dispensing machines such as RxNow.
- Perform other assigned pharmacy support tasks.
- Long Term Care pharmacy experience.
BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.
Company Size
10,001+
Company Stage
Post IPO Equity
Headquarters
Louisville, Kentucky
Founded
1974
Get referred to BrightSpring Health Services
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue rose 23% to $3.87 billion, with EBITDA up 44%.
- Management raised 2026 EBITDA guidance to $820 million-$845 million on August 1, 2026.
- Debt refinancing lowered spreads 50 basis points after S&P and Moody's upgrades.
What critics are saying
- FTC forced BrightSpring's 2026 community-living sale, stripping growth from IDD services.
- IRA reimbursement cuts still hit 2026 revenue by about $45 million quarterly.
- Amedisys and LHC integrations can stumble, delaying promised $35 million EBITDA.
What makes BrightSpring Health Services unique
- BrightSpring links specialty pharmacy and home-based services for complex chronic patients nationwide.
- Specialty pharmacy added 12 new limited-distribution drugs in 2026, deepening drug access.
- Amedisys and LHC branches expand home-health density and certificate-of-need coverage.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↓ -10%1 year growth
↓ -10%2 year growth
↓ -10%BrightSpring Health Services exceeded Wall Street expectations in Q2, delivering revenue of $3.87 billion and adjusted earnings per share of $0.45, beating analyst estimates by 5.9% and 13% respectively. The company's Specialty and Infusion pharmacy business drove growth, with revenue up 30% and script growth of 31% year-over-year. CEO Jon Rousseau attributed the performance to new limited distribution drug launches and broad-based volume growth. However, segments like Home and Community Pharmacy faced challenges from customer exits and regulatory headwinds. The company raised its full-year revenue guidance to $15.26 billion at the midpoint, up 1.9% from previous guidance. Operating margin improved to 3.4%, compared to 1.5% in the prior-year quarter. Despite the strong results, the market reacted negatively, reflecting concerns about underlying business headwinds.
Micron Technology, BrightSpring Health Services, and Custom Truck One Source have emerged as standout profitable stocks based on strong net income ratios and growth prospects. The selection criteria included a Zacks Rank of #1, trailing 12-month sales and net income growth exceeding industry averages, and a net income ratio higher than the industry standard. Micron Technology, a global memory and storage provider, shows particularly impressive metrics with a 12-month net profit margin of 55.9%. The company's expected earnings growth rate for the current year stands at 791%. The screening process, using the Zacks Research Wizard, filtered more than 7,685 stocks down to just 13 that met all criteria. The net income ratio helps investors assess a company's ability to cover both operating and non-operating expenses with revenues.
BrightSpring Health Services shares fell 17.5% after reporting second-quarter results, despite beating expectations. The healthcare services provider posted revenue of $3.87 billion, up 23% year-on-year, whilst non-GAAP profit reached $0.45 per share, exceeding forecasts. The company also raised its full-year guidance. However, investors responded negatively in what appeared to be a "sell-the-news" reaction. The sell-off may stem from valuation concerns and stagnant profit margins despite rising sales, raising questions about the company's cost structure. The stock has experienced 18 movements greater than 5% over the past year. At $59.71 per share, BrightSpring trades 18.1% below its 52-week high of $72.91 from July, though it remains up 55.5% year-to-date.
BrightSpring Health Services reported strong second-quarter 2026 results, with total revenue reaching $3.9 billion, up 23% year-over-year. Adjusted EBITDA rose 44% to $206 million, exceeding expectations. The company's Pharmacy Solutions segment drove growth, with specialty and infusion revenue climbing 30%. Provider Services revenue increased 30%, supported by robust home health care volume growth and successful integration of Amedisys and LHC branches, expected to contribute approximately $35 million in EBITDA for 2026. BrightSpring reduced leverage to 2.15 times as of 30 June and secured credit rating upgrades from S&P and Moody's. The company refinanced debt at 50 basis points lower spread. Management raised full-year 2026 adjusted EBITDA guidance to between $820 million and $845 million, representing 32.8% to 36.8% growth, with expected operating cash flow of approximately $600 million.
Why BrightSpring Health Services (BTSG) shares are trading lower today. What Happened? Shares of healthcare services provider BrightSpring Health Services BTSGfell 17.5% in the afternoon session after the company reported strong second-quarter results and increased its full-year guidance, prompting a "sell-the-news" reaction from investors. BrightSpring announced that second-quarter revenue grew 23% year-on-year to $3.87 billion, while its non-GAAP profit of $0.45 per share also beat expectations. In addition, the company lifted its financial outlook for the full year. However, the positive results were not enough to satisfy investors, who pushed the stock lower. The sell-off could be linked to valuation concerns, as the company's own earnings report noted that its stock price already reflected a lot of good news. The report also highlighted stagnant profit margins despite rising sales, raising questions about the company's cost structure. What Is The Market Telling Us BrightSpring Health Services's shares are quite volatile and have had 18 moves greater than 5% over the last year. But moves this big are rare even for BrightSpring Health Services and indicate this news significantly impacted the market's perception of the business. The biggest move we wrote about over the last year was 3 months ago when the stock gained 10.1% on the news that the company reported robust first-quarter 2026 financial results that surpassed analyst expectations and raised its full-year guidance. BrightSpring announced a 25.6% year-over-year increase in revenue to $3.61 billion, which was 6.3% ahead of consensus estimates. The company's profitability also showed significant strength. GAAP earnings per share came in at $0.67, substantially beating the $0.27 analysts had projected. Additionally, its adjusted EBITDA of $189.8 million surpassed expectations by over 11%.Buoyed by the strong performance, the company increased its financial forecast for the full year. BrightSpring lifted its full-year revenue guidance to a midpoint of $14.98 billion and its adjusted EBITDA guidance to a midpoint of $810 million, both figures coming in above Wall Street's projections. This strong beat-and-raise quarter signaled positive business momentum, driving investor confidence in the stock. BrightSpring Health Services is up 55.5% since the beginning of the year, but at $59.71 per share, it is still trading 18.1% below its 52-week high of $72.91 from July 2026. Investors who bought $1,000 worth of BrightSpring Health Services's shares at the IPO in January 2024 would now be looking at an investment worth $5,427. ALSO WORTH WATCHING: Nvidia's Quiet Partner. Nvidia's chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all. Every AI server needs specialized infrastructure the chip companies don't make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar.